# Neuropharma, Inc. — Form D

Neuropharma, Inc. of PARK CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-04. The offering totals $5.2M, of which $2.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-12-04
- Form: D
- Accession: 0001834263-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.2M
- Amount sold: $2.1M
- Remaining: $3.2M
- Investors: 7
- Date of first sale: 2020-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-382261

## Issuer

- Name: Neuropharma, Inc.
- CIK: 0001834263
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 52 WHITE PINE CANYON RD., PARK CITY, UT, 84060
- Phone: (650) 464-9129

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Jed Black | Director | Park City, UT |
| Jed Black | Executive Officer | Park City, UT |

## More

- [CIK 1834263 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1834263&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001834263-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.